Rigosertib promotes ferroptosis in colorectal cancer by increasing Keap1, reducing Nrf2/SLC7A11 signaling, and facilitating autophagic GPX4 degradation
- DOI
- 10.1016/j.cellsig.2026.112995
- Published
- 2026-11
- Container
- Cellular Signalling
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.cellsig.2026.112995,
title = {Rigosertib promotes ferroptosis in colorectal cancer by increasing Keap1, reducing Nrf2/SLC7A11 signaling, and facilitating autophagic GPX4 degradation},
author = {Yongkang Shi and Qiliang Lu and Ziwei Wang and Shanen Jin and Yue Wu and Long Zhang and Jun Ma},
year = {2026},
journal = {Cellular Signalling},
doi = {10.1016/j.cellsig.2026.112995},
url = {https://doi.org/10.1016/j.cellsig.2026.112995}
}RIS
TY - JOUR TI - Rigosertib promotes ferroptosis in colorectal cancer by increasing Keap1, reducing Nrf2/SLC7A11 signaling, and facilitating autophagic GPX4 degradation AU - Yongkang Shi AU - Qiliang Lu AU - Ziwei Wang AU - Shanen Jin AU - Yue Wu AU - Long Zhang AU - Jun Ma PY - 2026 JO - Cellular Signalling DO - 10.1016/j.cellsig.2026.112995 UR - https://doi.org/10.1016/j.cellsig.2026.112995 ER -
APA
Shi, Y., Lu, Q., Wang, Z., Jin, S., Wu, Y., Zhang, L., & Ma, J. (2026). Rigosertib promotes ferroptosis in colorectal cancer by increasing Keap1, reducing Nrf2/SLC7A11 signaling, and facilitating autophagic GPX4 degradation. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112995
Source records
- crossref · retrieved 2026-11-09T08:59:40.591Z